Understanding why racial/ethnic inequities along the HIV care continuum persist in the United States: a qualitative exploration of systemic barriers from the perspectives of African American/Black and Latino persons living with HIV

Table 2 Health factors (N = 41)

	Mean (SD) or %	N
Years living with HIV/years since HIV Diagnosis (M, SD)	18.8 (8.93)
Median, [minimum, maximum], in years	19.0 [1.00, 37.0]
Perinatally infected with HIV	0.0	0/41
Has taken HIV medication in the past	95.1	39/41
Years since first initiated HIV medication	16.7 (8.74)
Median, [minimum, maximum], in years	15.5 [1.00, 38.0]
Number of HIV medication starts (range 0–288 times)	6.08 (7.93)
Longest duration of sustained HIV medication over the lifetime, in months	34.3 (41.6)
Median, [minimum, maximum], in months	24.0 [1.00, 240]
Took at least one dose of any HIV medication in the past 4 weeks	75.6	31/41
Adherence to HIV medication - past month (range 0–100)	59.9 (37.0)
If not on any HIV medication at enrollment, number of months since last dose	6.40 (5.64)
Median, [minimum, maximum], in months	4.10 [1.50, 18.4]
Is covered by public health insurance (e.g., Medicare, Medicaid)	97.5	40/41
Satisfaction with HIV care (range 0–100)	76.8 (23.6)
Evidenced HIV viral suppression at follow-up	41.5	17/41
Substance use
Alcohol Use at a Moderate-to-High Risk Level	60.9	25/41
Cannabis Use at a Moderate-to-High Risk Level	43.9	18/41
Cocaine Use at a Moderate-to-High Risk Level	31.7	13/41
Polysubstance Use (2 + substances excluding tobacco and alcohol) at a Moderate-to-High Risk Level	41.5	17/41
Any Substance Use Treatment Lifetime	73.2	30/41

ISSN: 1475-9276